Association of Polymorphisms in Regulatory Regions of Interleukin-12p40 Gene and Cytokine Serum Level with Colorectal Cancer

REFERENCES

• Lin, W.W.; Karin, M.A. Cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007, 117(5), 1175–1183.
   PubMed Web of Science ®Google Scholar
• Hoelscher, C. The power of combinatorial immunology: IL-12 and IL-12-related dimeric cytokines in infectious diseases. Med Microbiol Immuno 2004, 193(1), 1–17.
   PubMed Web of Science ®Google Scholar
• Han, S.S.; Cho, E.Y.; Lee, T.S.; Kim, J.W.; Park, N.H.; Song, Y.S.; Kim, J.G.; Lee, H.P.; Kang, S.B. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical caner in Korean women. Eur J Obstet Gynecol Reprod Biol 2008, 140(1), 71–75.
   PubMed Web of Science ®Google Scholar
• Navaglia, F.; Basso, D.; Zambon, C.F.; Ponzano, E.; Caenazzo, L.; Gallo, N.; Falda, A.; Belluco, C.; Fogar, P.; Greco, E.; Di Mario, F.; Rugge, M.; Plebani, M. Interleukin 12 gene polymorphisms enhance gastric cancer risk in H. pylori infected individuals. J Med Genet 2005, 42(6), 503–510.
   PubMed Web of Science ®Google Scholar
• Howell, W.M.; Turner, S.J.; Theaker, J.M.; Bateman, A.C. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 2003, 30(6), 409–414.
   PubMedGoogle Scholar
• Nieters, A.; Yuan, J.M.; Sun, C.L.; Zhang, Z.Q.; Stoehlmacher, J.; Govindarajan, S.; Yu, M.C. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 2005, 103(4), 740–748.
   PubMed Web of Science ®Google Scholar
• Morahan, G.; Huang, D.; Ymer, S.I.; Cancilla, M.R.; Stephen, K.; Dabadghao, P.; Werther, G.; Tait, B.D.; Harrison, L.C.; Colman, P.G. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001, 27(2), 218–221.
   PubMed Web of Science ®Google Scholar
• Seegers, D.; Zwiers, A.; Strober, W.; Pena, A.S.; Bouma, G. A TaqI polymorphism in the 3′UTR of the IL-12p40 gene correlates with increased IL-12 secretion. Genes Immun 2002, 3(7), 419–423.
   PubMed Web of Science ®Google Scholar
• Stanilova, S.; Miteva, L. Taq-I polymorphism in 3′UTR of the IL-12 and association with IL-12p40 production from human PBMC. Genes Immun 2005, 6(4), 364–366.
   PubMed Web of Science ®Google Scholar
• Morahan, G.; Huang, D.; Wu, M.; Holt, B.J.; White, G.P.; Kendall, G.E.; Sly, P.D.; Holt, P.G. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet 2002, 360(9331), 455–459.
   PubMed Web of Science ®Google Scholar
• Muller-Berghaus, J.; Kern, K.; Paschen, A.; Nguyen, X.D.; Klüter, H.; Morahan, G.; Schadendorf, D. Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun 2004, 5(5), 431–434.
   PubMed Web of Science ®Google Scholar
• Stanilova, S.; Miteva, L.; Prakova, G. IL-12Bpro and GSTP1 polymorphisms in association with silicosis. Tissue Antigens 2008, 71(2), 169–174.
   PubMed Web of Science ®Google Scholar
• O'Hara, R.J.; Greenman, J.; MacDonald, A.W.; Gaskell, K.M.; Topping, K.P.; Duthie, G.S.; Kerin, M.J.; Lee, P.W.; Monson, J.R. Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res 1998, 4(8), 1943–1948.
   PubMed Web of Science ®Google Scholar
• Shibata, M.; Nezu, T.; Kanou, H.; Abe, H.; Takekawa, M.; Fukuzawa, M. Decreased production of interleukin-12 and type 2 immune responses are marked in cachectic patients with colorectal and gastric cancer. J Clin Gastroenterol 2002, 34(4), 416–420.
   PubMed Web of Science ®Google Scholar
• Nakayama, Y.; Sako, T.; Shibao, K.; Onitsuka, K.; Nagashima, N.; Hirata, K.; Nagata, N.; Itoh, H. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer. Anticancer Res 2000, 20(6A), 4097–4102.
   PubMed Web of Science ®Google Scholar
• Inoue, Y.; Nakayama, Y.; Minagawa, N.; Katsuki, T.; Nagashima, N.; Matsumoto, K.; Shibao, K.; Tsurudome, Y.; Hirata, K.; Nagata, N.; Itoh, H. Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer. Anticancer Res 2005, 25(5), 3541–3546.
   PubMed Web of Science ®Google Scholar
• Murakami, S.; Okubo, K.; Tsuji, Y.; Sakata, H.; Hamada, S.; Hirayama, R. Serum interleukin-12 levels in patients with gastric cancer. Surg Today 2004, 34(12), 1014–1019.
   PubMed Web of Science ®Google Scholar
• Hou, L.; El-Omar, E.M.; Chen, J.; Grillo, P.; Rabkin, C.S.; Baccarelli, A.; Yeager, M.; Chanock, S.J.; Zatonski, W.; Sobin, L.H.; Lissowska, J.; Fraumeni, J.F., Jr.; Chow, W.H. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007, 28(1), 118–113.
   PubMed Web of Science ®Google Scholar
• Theodoropoulos, G.; Papaconstantinou, I.; Felekouras, E.; Nikiteas, N.; Karakitsos, P.; Panoussopoulos, D.; Lazaris, A.Ch.; Patsouris, E.; Bramis, J.; Gazouli, M. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 2006, 12(31), 5037–5043.
   PubMed Web of Science ®Google Scholar
• Landi, S.; Moreno, V.; Gioia-Patricola, L.; Guino, E.; Navarro, M.; de Oca, J.; Capella, G.; Canzian, F.; Bellvitge Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 2003, 63(13), 3560–3566.
   PubMed Web of Science ®Google Scholar
• García-González, M.A.; Lanas, A.; Wu, J.; Benito, R.; Santolaria, S.; Crusius, B.; Peña, S. Lack of association of IL-12p40 gene polymorphism with peptic ulcer disease. Hum Immunol 2005, 66(1), 72–76.
   PubMed Web of Science ®Google Scholar
• Seegers, D.; Borm, M.E.; van Belzen, M.J.; Mulder, C.J.; Bailing, J.; Crusius, J.B.; Meijer, J.W.; Wijmenga, C.; Peña, A.S.; Bouma, G. IL12B and IRF1 gene polymorphisms and susceptibility to celiac disease. Eur J Immunogenet 2003, 30(6), 421–425.
   PubMedGoogle Scholar
• D'Andrea, A.; Rengaraju, M.; Valiante, N.M.; Chehimij, J.; Kubin, M.; Aste, M.; Chan, S.; Kobatashi, M.; Young, D.; Nickbarg, E.; Chizzonite, R.; Wolf, S.; Trinchieri, G. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992, 176(5), 1387–1398.
   PubMed Web of Science ®Google Scholar
• Colombo, M.P.; Trinchieri, G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 2002, 13(2), 155–168.
   PubMed Web of Science ®Google Scholar
• Lo, C.H.; Lee, S.C.; Wu, P.Y.; Pan, W.Y.; Su, J.; Cheng, C.W.; Roffler, S.R.; Chiang, B.L.; Lee, C.N.; Wu, C.W.; Tao, M.H. Antitumor and antimetastatic activity of IL-23. J Immunol 2003, 171(2), 600–607.
   PubMed Web of Science ®Google Scholar
• Hao, J.S.; Shan, B.E. Immune enhancement and anti-tumour activity of IL-23. Cancer Immunol Immunother 2006, 55(11), 1426–1431.
   PubMed Web of Science ®Google Scholar
• Langowski, J.L.; Zhang, X.; Wu, L.; Mattson, J.D.; Chen, T.; Smith, K.; Basham, B.; McClanahan, T.; Kastelein, R.A.; Oft, M. IL-23 promotes tumour incidence and growth. Nature 2006, 442(7101), 461–465.
   PubMed Web of Science ®Google Scholar